RTC-4202

N/A

Report date: 2025/12/05 17:17:07
NME

Base Information

Drug NameRTC-4202
Drug Alias NameRTC-4202
ClassificationSmall molecules
Mechanisms of ActionComplement factor B inhibitors
TargetsComplement factor B
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRipple Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesRipple Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A